28.01.2014 Views

PDF (2,8 MB) - Úrad priemyselného vlastníctva SR

PDF (2,8 MB) - Úrad priemyselného vlastníctva SR

PDF (2,8 MB) - Úrad priemyselného vlastníctva SR

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

VESTNÍK ÚRADU PRIEMYSELNÉHO VLASTNÍCTVA <strong>SR</strong> 6 - 2010 - SK (preklady patentov) 37<br />

(73) Bristol-Myers Squibb Company, Princeton, NJ, US;<br />

(72) CHEN Bang-Chi, Plainsboro, NJ, US; DROG-<br />

HINI Roberto, Candiac, Quebec, CA; LAJEU-<br />

NESSE Jean, Candiac, Quebec, CA; DIMARCO<br />

John D., East Brunswick, NJ, US; GALELLA<br />

Michael, Kendall Park, NJ, US; CHIDA<strong>MB</strong>A-<br />

RAM Ramakrishnan, Pennington, NJ, US;<br />

(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />

SK;<br />

(86) PCT/US2005/003728<br />

(87) WO 2005/077945<br />

(54) Spôsob prípravy 2-aminotiazol-5-aromatických<br />

karboxamidov ako inhibítorov kinázy<br />

(51) C07D 333/00<br />

(11) E 6924<br />

(96) 07004341.9, 2.3.2007<br />

(97) 1964838, 30.12.2009<br />

(24) 30.12.2009<br />

(73) EDMOND PHARMA S.R.L., Milano, IT;<br />

(72) Nicola Massimo, Pavia, IT; Gatti Pier Andrea, San<br />

Genesio ed Uniti, IT; Zacche Matteo, Vanzago, IT;<br />

(74) Fajnorová Mária, Ing., Bratislava, SK;<br />

(54) Spôsob rozdelenia homocysteín-tiolaktónu<br />

(51) C07D 401/00, A61K 31/473, A61P 11/00<br />

(11) E 6840<br />

(96) 06708593.6, 1.3.2006<br />

(97) 1856093, 2.12.2009<br />

(24) 2.12.2009<br />

(31) 05101619, 05108442<br />

(32) 2.3.2005, 14.9.2005<br />

(33) EP, EP<br />

(73) Nycomed GmbH, Konstanz, DE;<br />

(72) KAUTZ Ulrich, Allensbach, DE; WEBEL Matthias,<br />

Radolfzell, DE; SCHEUFLER Christian,<br />

Engen-Neuhausen, DE; HUMMEL Rolf-Peter,<br />

Radolfzell, DE;<br />

(74) Majlingová Marta, Ing., Bratislava, SK;<br />

(86) PCT/EP2006/060377<br />

(87) WO 2006/092422<br />

(54) (2R,4aR, 10bR)-6-(2,6-dimetoxypyridín-3-yl)-<br />

-9-etoxy-8-metoxy-1,2,3,4,4a, 10b-hexahydro-fenantridín-2-ol,<br />

HCI soľ<br />

(51) C07D 401/00<br />

(11) E 6932<br />

(96) 03772096.8, 29.7.2003<br />

(97) 1537097, 2.12.2009<br />

(24) 2.12.2009<br />

(31) 400356 P, 446451 P<br />

(32) 31.7.2002, 11.2.2003<br />

(33) US, US<br />

(73) E.I. DU PONT DE NEMOURS AND COMPA-<br />

NY, Wilmington, Delaware, US;<br />

(72) ANNIS Gary David, Landenberg, PA, US;<br />

(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />

SK;<br />

(86) PCT/US2003/023820<br />

(87) WO 2004/011453<br />

(54) Spôsob prípravy 3-halogén-4,5-dihydro-1H-pyrazolov<br />

(51) C07D 401/00, A61K 31/4427, A61P 29/00,<br />

A61P 25/00, A61P 17/00, A61P 15/00,<br />

A61P 13/00, A61P 11/00, A61P 3/00,<br />

C07D 213/00, C07D 403/00<br />

(11) E 6906<br />

(96) 07823371.5, 30.7.2007<br />

(97) 2049525, 30.12.2009<br />

(24) 30.12.2009<br />

(31) 0606988<br />

(32) 31.7.2006<br />

(33) FR<br />

(73) Sanofi-Aventis, Paris, FR;<br />

(72) Dubois Laurent, Paris, FR; Evanno Yannick, Paris,<br />

FR; Malanda André, Paris, FR; Machnik David,<br />

Paris, FR; Gille Catherine, Paris, FR;<br />

(74) Čechvalová Dagmar, Bratislava, SK;<br />

(86) PCT/FR2007/001316<br />

(87) WO 2008/015335<br />

(54) N-(aminoheteroaryl)-1H-indol-2-karboxamidové<br />

deriváty, ich príprava a ich terapeutické použitie<br />

(51) C07D 401/00, A61K 31/4468, A61K 31/4523<br />

(11) E 6869<br />

(96) 05813800.9, 26.10.2005<br />

(97) 1919896, 23.12.2009<br />

(24) 23.12.2009<br />

(31) CH11272005<br />

(32) 12.8.2005<br />

(33) IN<br />

(73) Suven Life Sciences Limited, Hyderabad (Andra<br />

Pradesh), IN;<br />

(72) Ramakrishna Venkata Satya Nirogi, Andhra Pradesh,<br />

IN; Shirsath Vikas Shreekrishna, Andhra<br />

Pradesh, IN; Kambhampati Rama Sastri, Andhra<br />

Pradesh, IN; Vishwakarma Santosh, Andhra Pradesh,<br />

IN; Kandikere Na-garaj Vishwottam, Andhra<br />

Pradesh, IN; Kota Srinivasulu, Andhra Pradesh,<br />

IN; Jasti Venkateswarlu, Andhra Pradesh, IN;<br />

(74) ŽOVICOVÁ & ŽOVIC IP, s. r. o., Bratislava, SK;<br />

(86) PCT/IN2005/000345<br />

(87) WO 2007/020652<br />

(54) Aminoarylsulfónamidové deriváty ako funkčné<br />

5-HT 6 ligandy<br />

(51) C07D 401/00, A61K 31/4523, A61P 37/00,<br />

A61P 11/00<br />

(11) E 6900<br />

(96) 06841477.0, 19.12.2006<br />

(97) 1963307, 25.11.2009<br />

(24) 25.11.2009<br />

(31) 0525897, 0623217<br />

(32) 20.12.2005, 21.11.2006<br />

(33) GB, GB<br />

(73) GLAXO GROUP LIMITED, Greenford, Middlesex,<br />

GB;<br />

(72) HODGSON Simon Teanby, Stevenage Hertfordshire,<br />

GB; PROCOPIOU Panayiotis Alexandrou,<br />

Stevenage Hertfordshire, GB; Vinader Brugarolas<br />

Maria Victoria, Stevenage Hertfordshire, GB;<br />

(74) Majlingová Marta, Ing., Bratislava, SK;<br />

(86) PCT/EP2006/069943<br />

(87) WO 2007/071691<br />

(54) Kyselina 3-(4-{[4-(4-{[3-(3,3-dimetyl-1-piperidinyl)propyl]oxy}fenyl)-1-piperidinyl]karbonyl}-1-naftalenyl)-propánová<br />

alebo propénová<br />

ako antagonista H3 receptora na liečenie zápalových<br />

a/alebo alergických ochorení

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!